ArticleOncoTargets and therapy2024

Hyperbilirubinemia in a Patient Receiving Alectinib for Anaplastic Lymphoma Kinase Positive Non-Small-Cell Lung Cancer: A Histological Features.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.